News for GENEREX BIOTECHNOLOGY CORP (GNBT)

News for GENEREX BIOTECHNOLOGY CORP
Date Headline
Jul 02, 2018 09:00 AM Generex Biotechnology Corporation Announces the Filing of a Patent for its New Diagnostic Point-of-Care Platform, the Express II
Jun 25, 2018 09:00 AM Generex Announces Terry Thompson as Chief Operating Officer
Jan 04, 2018 08:30 AM Generex CEO Provides 2017 Year-End Summary to Stakeholders
Jan 03, 2018 11:00 AM Generex Provides Access Information for Investor Conference Call Scheduled for January 4, 2018
Jan 03, 2018 09:00 AM Generex Announces Initial Pharmacy Acquisitions & Plans for Broader Acquisitions Strategy
Jan 02, 2018 09:00 AM Generex Confirms Receipt of $700,000 USD License Fee from Shenzhen BioScien Pharmaceuticals
Dec 18, 2017 09:30 AM Generex Announces Investor Conference Call; Management to Provide Update on Initiatives & Strategic Plans
Dec 07, 2017 11:30 AM Generex Announces Collaboration with Shenzhen BioScien Pharmaceuticals to Develop and Commercialize the AE37 Immunotherapeutic Vaccine for the Treatment of Prostate Cancer in China
Nov 30, 2017 09:00 AM Generex Announces Upgrade to OTCQB® Venture Market
Nov 27, 2017 09:00 AM Generex Announces Results of Annual Stockholders’ Meeting